It is anticipated that there will be supply shortage of salbutamol inhalation solution 2.5mg/2.5mL (Ventolin Nebules) from November 2023 to August 2024. This anticipated shortage does not apply to salbutamol inhalation solution 5mg/2.5mL (Ventolin Nebules).
Salbutamol Cipla 2.5mg/2.5mL brand is also unavailable.
An unregistered product (pms-SALBUTAMOL salbutamol sulphate inhalation solution, BP 1mg/1mL (2.5mg/2.5mL) (Canada)) has been approved for supply under Section 19A until 1 September 2024. This brand is included on the PBS from 1 February 2024.
Download the February 2024 update with recommendations and references
